Add
BIOL to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| BIOL > SEC Filings for BIOL > Form 8-K on 16-Apr-2012 | All Recent SEC Filings |
16-Apr-2012
Results of Operations and Financial Condition, Regulation FD Disclosure, F
On April 16, 2012, Biolase Technology, Inc. (the "Company") issued a press release announcing preliminary financial results for the first quarter ended March 31, 2012.
A copy of the Company's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated by reference herein.
On April 16, 2012, the Company issued a press release announcing the completion of its purchase of certain laser systems from Henry Schein, Inc.
A copy of the Company's press release is filed as Exhibit 99.2 to this Current Report on Form 8-K, and is incorporated by reference herein.
d) Exhibits.
99.1 Press Release of Biolase Technology, Inc., dated April 16, 2012.
99.2 Press Release of Biolase Technology, Inc., dated April 16, 2012.
This Current Report on Form 8-K and the information contained in the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K and the press release is not incorporated by reference into any filings of the Company, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing, unless explicitly incorporated by specific reference into such filing.
|
|